Recent Press Releases

NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines

NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines ROCKVILLE, Md., Jul 5, 2012 -- Novavax, Inc. NVAX +4.09% reported this week that Gregory Glenn, M.D.,...

Argos Therapeutics Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial International ADAPT Study for Treatment of Metastatic Renal Cell Carcinoma Underway

Argos Therapeutics Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial International ADAPT Study for Treatment of Metastatic Renal Cell Carcinoma Underway DURHAM, N.C., Jul...

European Medicines Agency gives first opinion for a vaccine for use outside the EU

European Medicines Agency gives first opinion for a vaccine for use outside the EU New vaccine offers protection against six WHO priority diseases 22/06/2012 The European Medicines Agency has issued...

New Innovative Vaccine Refrigerator Protects Vaccines During Power Outages Without Backup Power

TORONTO, ONTARIO, Jun 25, 2012 -- Backup-Power.ca announces the launch of the new BFRV84 vaccine refrigerator that protects vaccines for up to 4 days during a power outage without requiring backup...

Walgreens Offering Pertussis (Whooping Cough) Vaccine at All of Its 67 Points of Care Across Kansas as State Nears Epidemic Levels

DEERFIELD, Ill., Jun 22, 2012 -- With epidemic levels of whooping cough reported in the state of Kansas and creating the need for more immunizations resources, Walgreens (NYSE, NASDAQ: WAG) is...

Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants

PRINCETON, N.J., June 27, 2012 -- Soligenix, Inc. SNGX +4.26% (Soligenix or the Company), a development stage biopharmaceutical company, announced today that it has entered into a...

Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain

In the journal Science Translational Medicine, the scientists describe how a single dose of their novel vaccine protects mice, over their lifetime, against nicotine addiction. The vaccine is designed...

BioDiem acquires rights to novel hepatitis vaccine technology from University of Canberra

Melbourne, 26 June 2012: Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today that it has signed an agreement to license a novel vaccine...

Dynavax Announces FDA Acceptance of HEPLISAV(TM) BLA

BERKELEY, CA -- 06/26/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the Food and Drug Administration (FDA) has accepted for review the U.S. Biologics License Application...

Early vaccinations not linked to celiac disease in sweden

To investigate whether changes in the national Swedish vaccination program coincided with changes in the incidence of CD in infants, Anna Myléus, Ph.D., M.D., from Umeå University in...

Swine flu vaccination programme a success in Scotland

The H1N1- 'swine 'flu-' vaccination programme introduced in Scotland in October 2009 had a positive effect in reducing the number of hospital admissions and deaths as a result of H1N1...

New CDC test for dengue approved

The Centers for Disease Control and Prevention has developed a new diagnostic test to detect the presence of dengue virus in people with symptoms of dengue fever or dengue hemorrhagic fever. The...

BioDiem signs full agreement with ANU for Dengue Fever vaccine technology

Melbourne, 25 June 2012: Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today the signing of a licensing agreement with Australian National...

Sanofi Pasteur's 6-in-1 Pediatric Vaccine Hexaxim™ Receives Positive Opinion from European Medicines Agency

France, Lyon – June 22, 2012 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that HexaximTM (DTaP-IPV-Hib-HepB vaccine) received a...

Biovest Initiates Formal Regulatory Approval Process for BiovaxID® Cancer Vaccine in Europe

Biovest Initiates Formal Regulatory Approval Process for BiovaxID® Cancer Vaccine in Europe 06/20/12 Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia...

Anti-cocaine vaccine described in Human Gene Therapy Journal

Anti-cocaine vaccine described in Human Gene Therapy Journal New Rochelle, NY, June 18, 2012—A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel...

Controversial vaccine trial should never have been run in India, researchers say

Controversial vaccine trial should never have been run in India, researchers say Thursday 21 June 2012 Research published today in the Journal of the Royal Society of Medicine raises further...

CSL Biotherapies provides update on Fluvax® investigation

CSL Biotherapies (CSL) today presented preliminary conclusions from its investigations into the cause of the unexpected adverse events associated with Fluvax® influenza vaccine in 2010. The...

PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program

PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program Completes Release of Final Drug Product ANNAPOLIS, Md., June 14, 2012 /PRNewswire/ -- PharmAthene,...

GSK receives FDA approval for MenHibrix

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix® [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate...